News & Updates
Filter by Specialty:
AKI duration tied to CKD, CVD risk
The duration of acute kidney injury (AKI) was associated with the risks of chronic kidney disease (CKD) but not overall cardiovascular disease (CVD*), a population-based Danish cohort study suggests.
AKI duration tied to CKD, CVD risk
27 Jul 2023
Niraparib maintenance confers prolonged survival in advanced ovarian cancer
Maintenance therapy with niraparib appears to increase progression-free survival (PFS) in patients with advanced ovarian cancer, irrespective of postoperative residual disease or biomarker status, according to data from the phase III PRIME study.
Niraparib maintenance confers prolonged survival in advanced ovarian cancer
27 Jul 2023
Adverse birth outcomes tied to increase T2D risk high among certain postmenopausal women
For postmenopausal women with a history of gestational diabetes, delivering high birth weight infants or hypertensive disorders of pregnancy poses a heightened risk of developing type 2 diabetes (T2D) in the future, according to a study.
Adverse birth outcomes tied to increase T2D risk high among certain postmenopausal women
26 Jul 2023
Intranasal vardenafil works faster than oral formulation for ED
Vardenafil (VDF), an effective treatment for erectile dysfunction, administered by an intranasal spray formulation achieves faster but similar plasma concentration with only about one-third dose relative to oral VDF tablet, according to a study.
Intranasal vardenafil works faster than oral formulation for ED
26 Jul 2023
Cilta-cel a new Soc for lenalidomide-refractory MM?
In patients with lenalidomide-refractory multiple myeloma (MM), a single infusion of ciltacabtagene autoleucel (cilta-cel), a dual-binding BCMA*-directed chimeric antigen receptor (CAR) T-cell therapy, improved progression-free survival (PFS) compared with standard of care** (SoC), according to the phase III CARTITUDE-4 trial.
